USD 0.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | -523 Thousand | -964 Thousand |
Net Income | - | - | - | - | -2.83 Million | -3.1 Million |
Depreciation & Amortization | - | - | - | - | - | 91 Thousand |
Deferred income taxes | - | - | - | - | - | 90 Thousand |
Stock-based compensation | - | - | - | - | 1.52 Million | 1.18 Million |
Change in working capital | - | - | - | - | 227 Thousand | 502 Thousand |
Other non-cash items | - | - | - | - | 558 Thousand | 275 Thousand |
Investing Cash Flow | - | - | - | - | - | -150 Thousand |
Investments in PPE | - | - | - | - | - | -150 Thousand |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | -150 Thousand |
Financing Cash Flow | - | - | - | - | 725 Thousand | 983 Thousand |
Debt repayment | - | - | - | - | -725 Thousand | -40 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 11 Thousand |
Other Financing Activities | - | - | - | - | 1.45 Million | 1.01 Million |
Accounts receivables | - | - | - | - | - | 224 Thousand |
Accounts payables | - | - | - | - | - | 5000.00 |
Inventory | - | - | - | - | - | 336 Thousand |
Other working capital | - | - | - | - | 227 Thousand | -63 Thousand |
Cash at beginning of period | - | - | - | 269 Thousand | 67 Thousand | 183 Thousand |
Cash at end of period | - | - | - | 269 Thousand | 269 Thousand | 52 Thousand |
Capital Expenditure | - | - | - | - | - | -150 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | 202 Thousand | -131 Thousand |
Free Cash Flow | - | - | - | - | -523 Thousand | -1.11 Million |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2020 Q1 | 2019 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | -554 Thousand | -2.83 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | 139 Thousand | 1.52 Million |
Change in working capital | - | - | - | - | 41 Thousand | 227 Thousand |
Other non-cash items | - | - | - | - | 165 Thousand | 558 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | 725 Thousand |
Debt repayment | - | - | - | - | - | -725 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | 1.45 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | 41 Thousand | 227 Thousand |
Cash at beginning of period | - | - | - | 269 Thousand | 269 Thousand | 67 Thousand |
Cash at end of period | - | - | - | 269 Thousand | 60 Thousand | 269 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | -209 Thousand | 202 Thousand |
Free Cash Flow | - | - | - | - | -209 Thousand | -523 Thousand |
STBX
SMX
SBICARD
ARMANFIN
PSXRF
FAMILYCARE